How a cancer drug unties knots in the chromosome that causes Angelman and Prader-Willi syndromes (EurekAlert, 5 August 2013)

07 Aug 2013


A US study published in Proceedings of the National Academy of Sciences investigates epigenetic mechanisms behind the Angelman and Prader-Willi neurodevelopmental syndromes using a topoisomerase inhibitor in mouse models.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story